March 3, 2019 - Parkinson's Weekly Update

March 3, 2019 – Parkinson’s Weekly Update

This is a recap of the most interesting news and discussions relating to Parkinson’s Disease this past week. There was a lot of talk last week about the results of the Parkinson’s Disease trial in the UK involving a surgery that implanted tubes in patients’ heads that could be used post-surgery to deliver GDNF and would hopefully regenerate dying dopamine brain cells. On, the other side of the pond, the FDA is allowing a Fecal Microbiota Transplantation (yes, we’re talking about poop transplants) study to include Parkinson’s. Meanwhile in California, a stem cell PD trial moves closer to FDA approval. And ...
Beyond l-dopa for PD gait disturbances, balance issues and falls - CDP Choline?

Beyond l-dopa for PD gait disturbances, balance issues and falls – CDP Choline?

A study published this week raises an interesting point: Mobility deficits, including gait disturbance, balance impairments and falls, are common features of Parkinson's disease (PD) that negatively impact quality of life. Mobility deficits respond poorly to dopaminergic medications, indicating a role for additional neurotransmitters. Due to the critical role of cortical input to gait and balance, acetylcholine-an essential neurotransmitter system for attention-has become an area of interest for mobility. Overview of the cholinergic contribution to gait, balance and falls in Parkinson's disease I find this interesting, because the first Movement Disorder Specialist that I met with to confirm my Parknson’s ...